Doctor Takahiro Noto

Sapporo Medical University, Sapporo (Japan)

Follow

Contributor content

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

Presentation

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

ESC 365 is supported by

novartis

Explore sponsored resources